CytoSorbents Corp is a critical care immunotherapy leader commercializing its European Union approved CytoSorb blood purification technology to treat deadly inflammation in critically ill and cardiac surgery patients in around 55 countries. The company is conducting its pivotal REFRESH 2 - AKI cardiac surgery trial, designed to support U.S. FDA approval. The company's product portfolio consists of CytoSorb, ContrastSorb, VetResQ, HemoDefend and others. The company has around 19 issued U.S. patents, multiple patents issued internationally, and a broad patent application portfolio pending. Geographically it derives substantial revenue from product sales in Germany.
Quote | CytoSorbents Corporation (NASDAQ:CTSO)
Last: | $1.13 |
---|---|
Change Percent: | -5.83% |
Open: | $1.23 |
Close: | $1.20 |
High: | $1.23 |
Low: | $1.1124 |
Volume: | 37,630 |
Last Trade Date Time: | 08/01/2024 03:00:00 am |
News | CytoSorbents Corporation (NASDAQ:CTSO)
2024-08-01 07:46:52 ET More on Cytosorbents Cytosorbents Corporation (CTSO) Q1 2024 Earnings Call Transcript CytoSorbents reports regulatory approval of CytoSorb in Taiwan Read the full article on Seeking Alpha For further details see: CytoSorbents regain...
PRINCETON, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of deadly conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces that it has regained comp...
Message Board Posts | CytoSorbents Corporation (NASDAQ:CTSO)
Subject | By | Source | When |
---|---|---|---|
Plus they have a credit line facility in | Good Sport | investorshub | 07/09/2023 9:53:56 PM |
They won't run out of cash. They have | biotech48 | investorshub | 07/08/2023 9:31:48 PM |
When do they run out of cash? | ranchhand71 | investorshub | 07/07/2023 8:44:14 PM |
PR out that we've completed enrollment. | fantomphan | investorshub | 07/07/2023 12:28:30 PM |
Extracorporeal hemoadsorption therapy as a potential therapeutic option | Good Sport | investorshub | 07/07/2023 2:53:18 AM |
News, Short Squeeze, Breakout and More Instantly...
CytoSorbents Corporation Company Name:
CTSO Stock Symbol:
NASDAQ Market:
CytoSorbents Corporation Website:
PRINCETON, N.J., Aug. 01, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of deadly conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces that it has regained comp...
PRINCETON, N.J., July 29, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of deadly conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, is proud to announce the launch of ...
PRINCETON, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification via its proprietary polymer adsorption technology, announces it will present...